Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies
Viruses · 10.04.2023 · 15 (4) · 944
DOI: 10.3390/v15040944 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, online erschienen am 10.04.2023. Verfasst von Nur Zawanah Zabidi und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Science, Monash University Malaysia, Subang Jaya 47500, Selangor, Malaysia. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 123-mal zitiert (Crossref) und nennt 276 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National University of Singapore.
Abstract (Originalsprache)
The COVID-19 pandemic caused by SARS-CoV-2 is associated with a lower fatality rate than its SARS and MERS counterparts. However, the rapid evolution of SARS-CoV-2 has given rise to multiple variants with varying pathogenicity and transmissibility, such as the Delta and Omicron variants. Individuals with advanced age or underlying comorbidities, including hypertension, diabetes and cardiovascular diseases, are at a higher risk of increased disease severity. Hence, this has resulted in an urgent need for the development of better therapeutic and preventive approaches. This review describes the origin and evolution of human coronaviruses, particularly SARS-CoV-2 and its variants as well as sub-variants. Risk factors that contribute to disease severity and the implications of co-infections are also considered. In addition, various antiviral strategies against COVID-19, including novel and repurposed antiviral drugs targeting viral and host proteins, as well as immunotherapeutic strategies, are discussed. We critically evaluate strategies of current and emerging vaccines against SARS-CoV-2 and their efficacy, including immune evasion by new variants and sub-variants. The impact of SARS-CoV-2 evolution on COVID-19 diagnostic testing is also examined. Collectively, global research and public health authorities, along with all sectors of society, need to better prepare against upcoming variants and future coronavirus outbreaks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Science, Monash University Malaysia, Subang Jaya 47500, Selangor, Malaysia.
- Department of Respiratory Sciences, University of Leicester, Leicester LE1 7RH, UK.
- Infectious Diseases Translational Research Program, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore.
- Tropical Medicine & Biology Platform, Monash University, Subang Jaya 47500, Selangor, Malaysia.
ORCID-Profile: Nur Zawanah Zabidi, Hern Liang Liew, Isra Ahmad Farouk, Ashley Jia Wen Yip, Zheng Yao Low, Vincent T K Chow, Sunil K Lal
Förderung
- National University of Singapore
Zitieren
APA
Zabidi, N. Z., Liew, H. L., Farouk, I. A., Puniyamurti, A., Yip, A. J. W., Wijesinghe, V. N., Low, Z. Y., Tang, J. W., Chow, V. T. K., & Lal, S. K. (2023). Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies. Viruses, 15(4), 944. https://doi.org/10.3390/v15040944
Vancouver
Zabidi NZ, Liew HL, Farouk IA, Puniyamurti A, Yip AJW, Wijesinghe VN, et al. Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies. Viruses. 2023;15(4):944. doi:10.3390/v15040944
BibTeX
@article{Zabidi2023,
author = {Zabidi, Nur Zawanah and Liew, Hern Liang and Farouk, Isra Ahmad and Puniyamurti, Ashwini and Yip, Ashley Jia Wen and Wijesinghe, Vindya Nilakshi and Low, Zheng Yao and Tang, Julian W and Chow, Vincent T K and Lal, Sunil K},
title = {Evolution of SARS-CoV-2 Variants: Implications on Immune Escape, Vaccination, Therapeutic and Diagnostic Strategies},
journal = {Viruses},
year = {2023},
volume = {15},
number = {4},
pages = {944},
doi = {10.3390/v15040944}
}
EUVIMED